Thus, alterations in the NF-κB activation pathway may be upstream of changes in circulating immune biomarkers such as inflammatory proteins and CRP in (what appears to be) non-infective inflammation in people with schizophrenia. The gene discussed is NFKB1; the disease is schizophrenia.